Phase 1 NAC Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1
GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression
Hepatocellular CarcinomaImmunotherapySquamous Cell Lung Cancer+3 more
Second Affiliated Hospital of Guangzhou Medical University30 enrolled2 locationsNCT03198546
Completed
Phase 1
Determination of the Blood Pharmacodynamic Effects following a Single Dose of Oral Anatabine Citrate in Normal Healthy Volunteers
Pharmacodynamic effects study conducted in healthy volunteers with no health condition or problem studied.
This study is being conducted in healthy volunteers who are not being treated for the conditions that anatabine citrate are indicated for. Anatabine citrate is a naturally occurring alkaloid found in the Solanaceae plant family. It is also the ingredient of a number of dietary supplements.
Zenith Technology Corp Ltd10 enrolled1 locationACTRN12615000098538
Not Yet Recruiting
Phase 1
Comparative evaluation of the absorption and disposition in the body of a generic formulation of darifenacin 15 mg against the innovator product in healthy fed volunteers.
Bioequivalence assessment between two formulations of darifenacin 15 mg.
Center for Clinical Pharmacology Research Bdbeq S.A.24 enrolled1 locationACTRN12610000894099
Not Yet Recruiting
Phase 1
Comparative assessment of the absorption of a generic formulatons of darifenacin against the innovator darifenacin product in healthy volunteers.
Bioequivalence assessment between two formulations of darifenacin
Center for Clinical Pharmacology Research Bdbeq S.A.24 enrolled1 locationACTRN12610000883011